Company Overview
- Headquarters
- 7575 Gateway Blvd Suite 110, Newark CA
- Website
- cymabay.com
- Phone
- (510) 293-8800
- Employees
- 95
- Founded in
- 1991
- Industry
- Materials/Manufacturing
- Stock Symbol
- NASDAQ:CBA
- NAICS Code
-
NAICS Code 54 CompaniesNAICS Code 32541 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 325 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$20B
Total Funding Amount
$150M
Who is CymaBay Therapeutics
CymaBay Therapeutics is a clinical-stage biopharmaceutical company headquartered in India, founded in 2012. We are a medium-sized company with a focus on developing innovative therapies for liver and chronic diseases. CymaBay Therapeutics develops and provides access to innovative therapies for patients with liver and other chronic diseases. Our lead product, Seladelpar, is a PPARδ agonist in development for the treatment of primary biliary cholangitis (PBC). We are also developing additional investigational products for liver and other chronic diseases. CymaBay Therapeutics is committed to providing access to innovative therapies for patients with high unmet medical need. Contact information: cymabay.com
Company Leadership
CymaBay Therapeutics Industry Tags
CymaBay Therapeutics Tech Stack
Companies Similar to CymaBay Therapeutics
Analyze industry trends and opportunities by examining competitors and companies comparable to CymaBay Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 20M | 11 | Lansing, IL | 1961 | |
| 20M | 11 | Eynon, PA | ||
| 20M | 14 | Aurora, IL | 1989 | |
| 20M | 46 | Lenexa, KS | 1987 | |
| 20M | 60 |